Attached files
| file | filename |
|---|---|
| EX-31.2 - EXHIBIT 31.2 - NUGENEREX IMMUNO-ONCOLOGY, INC. | ex31_2.htm |
| EX-31.1 - EXHIBIT 31.1 - NUGENEREX IMMUNO-ONCOLOGY, INC. | ex31_1.htm |
| 10-Q - FORM 10-Q - NUGENEREX IMMUNO-ONCOLOGY, INC. | ngio013120form10q.htm |
Exhibit 32
CERTIFICATIONS
Pursuant to Section 906 of the Public Company Accounting Reform and Investor Protection Act of 2002 (18 U.S.C. ss. 1350, as adopted), Joseph Moscato, Chief Executive Officer and President of NuGenerex Immuno-Oncology, Inc.; (the "Company"), hereby certifies that, to the best of their knowledge:
1. The Company's Quarterly Report on Form 10-Q for the period ended January 31, 2020 to which this Certification is attached as Exhibit 32 (the "Report") fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and
2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the end of the period covered by the Report.
| DATE: June 17, 2020 | By: | /s/ Joseph Moscato |
| Joseph Moscato | ||
| President & Chief Executive Officer | ||
| By: | /s/ Mark Corrao | |
| Mark Corrao | ||
| Chief Financial Officer |